Clearbridge BioMedics sets up its US subsidiary, CBB Inc.
Clearbridge BioMedics announces the opening of its US subsidiary, Clearbridge BioMedics Inc (CBB Inc.). The new office is located in Carlsbad, CA. As of August 15, 2016 our US-based customers can now contact our representatives in the US office for product and general inquiries.
Clearbridge BioMedics, headquartered in Singapore, has been expanding globally since its label-free liquid biopsy technology was commercially launched in June 2014. Since then, our customer base has expanded to cover Asia Pacific, US and Europe. In the past year, Clearbridge BioMedics has been in the spotlight for its collaborations with world renowned companies and institutions such as Sysmex in Japan, the Institute of Cancer Research in the UK and most recently with Beijing Genomics Institute in China. Through the establishment of CBB Inc., the company is within easy reach of US-based research oncologists and clinicians, coming one step closer to its vision of making available timely, tailored treatment for cancer patients, a reality.
For all sales or product inquiries, please contact firstname.lastname@example.org
20-22 APRIL 2017 | San Francisco, USA | Plenary SessionLearn More
NewsGenomeWeb Feature: John Wayne Cancer Institute and Clearbridge BioMedics announce partnership to develop CTC CoRE in the U.S. PR Newswire: John Wayne Cancer Institute, and Clearbridge BioMedics announce partnership to develop Circulating Tumor Cell Centre of Research Excellence in the U.S. BioSpectrum: John Wayne Cancer Institute and Clearbridge BioMedics announce partnership
20-22 APRIL 2017 | San Francisco, USA | Plenary SessionRead more